[Myrin P in the combined treatment of tuberculosis].
作者信息
Sokolova G B, Semenova O V, Bogadel'nikova I V, Kunichan A D, Zeliger L R, Elistratova N A
机构信息
Research Institute of Phtisiopulmonology, I.M. Sechenov Moscow Medical Academy, Moscow.
出版信息
Antibiot Khimioter. 2002;47(6):22-7.
PMID:12422644
Abstract
Experimental and clinical evaluation of the new antimycobacterial quadrocomposition Myrin P was performed. The composition consists of isoniazid, rifampicin, pyrazinamide and ethambutol in fixed doses. The results of the formulation application at 474 patients with primary pulmonary tuberculosis caused by drug-susceptible and drug-resistant mycobacteria are presented. High efficacy and good tolerability of the formulation was demonstrated.
摘要
Zotero 插件